Atlas Trials

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Clinical trial NCT00683735 · COMPLETED

Trial details

NCT number
NCT00683735
Sponsor
Michael A. Nauck
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetes
Start date
2009-02-01
Primary completion
2012-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.